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Abstract
Background: Intensive care unit (ICU) patients age 90 years or older represent a growing subgroup and place a huge
financial burden on health care resources despite the benefit being unclear. This leads to ethical problems. The present
investigation assessed the differences in outcome between nonagenarian and octogenarian ICU patients.
Methods: We included 7900 acutely admitted older critically ill patients from two large, multinational studies. The
primary outcome was 30-day-mortality, and the secondary outcome was ICU-mortality. Baseline characteristics
consisted of frailty assessed by the Clinical Frailty Scale (CFS), ICU-management, and outcomes were compared
between octogenarian (80–89.9 years) and nonagenarian (> 90 years) patients. We used multilevel logistic regression to
evaluate differences between octogenarians and nonagenarians.
Results: The nonagenarians were 10% of the entire cohort. They experienced a higher percentage of frailty (58% vs
42%; p < 0.001), but lower SOFA scores at admission (6 + 5 vs. 7 + 6; p < 0.001). ICU-management strategies were
different. Octogenarians required higher rates of organ support and nonagenarians received higher rates of life-
sustaining treatment limitations (40% vs. 33%; p < 0.001). ICU mortality was comparable (27% vs. 27%; p = 0.973) but a
higher 30-day-mortality (45% vs. 40%; p = 0.029) was seen in the nonagenarians. After multivariable adjustment
nonagenarians had no significantly increased risk for 30-day-mortality (aOR 1.25 (95% CI 0.90–1.74; p = 0.19)).
Conclusion: After adjustment for confounders, nonagenarians demonstrated no higher 30-day mortality than octogenarian
patients. In this study, being age 90 years or more is no particular risk factor for an adverse outcome. This should be
considered– together with illness severity and pre-existing functional capacity - to effectively guide triage decisions.
Trial registration: NCT03134807 and NCT03370692.
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Introduction
The proportion of older patients has increased signifi-
cantly over time. In 2030, there will be more than 30
million people over the age of 90 (nonagenarians) in 35
industrialised countries [1]. Consequently, health care
providers nowadays perform medical procedures on very
old patients (from surgery to oncological therapies),
which were previously considered unfeasible because of
age or age-related deterioration in physical and mental
performance [2]. Similarly, the rate of older patients (> 80
years) in intensive care units (ICU) is increasing [3–6].
Today, older patients utilise a disproportionate amount of
health care resources compared to their relative propor-
tion of the total population [3, 7].
In particular, the extent to which “old age” per se is a
risk factor and the extent to which different groups of old
patients differ from one another regarding the prognosis
is the subject of continuing debate. Older patients suffer
worse outcomes than younger patients undergoing inten-
sive care [8, 9], but some studies failed to establish age as
an independent predictor of mortality in older ICU patients
[10, 11]. However, most prognostic studies demonstrated
an almost linear relationship between chronological age
and mortality after the age of 40 [12]. In this respect, pa-
tients ageing 80 years and more represent a particular chal-
lenge to intensive care medicine [13, 14]. Still, there are no
large studies that further differentiate this group of very old
ICU patients and it is unclear if being a nonagenarian is a
risk factor for adverse outcomes. We hypothesize that crit-
ically ill nonagenarians have an elevated 30-day mortality
compared to octogenarians. To address this hypothesis, we
performed a retrospective cohort study comprised of
two large, multinational prospective observational co-
horts [13–15]. This post-hoc analysis combined data
from the VIP-1 and VIP-2 studies to compare octo-
and nonagenarians regarding 30-day mortality (primary
outcome) and ICU mortality (secondary outcome), the




The very old intensive care patients (VIP) studies, VIP1 and
VIP2, were prospective, multi-centre studies, registered on
ClinicalTrials.gov (ID: NTC03134807, NCT03370692).
Both studies included very old intensive care patients
(VIPs), defined as patients admitted to an ICU and aged 80
years or older. The main results from these studies have
been published previously [13, 14, 16, 17]. In summary, for
both studies, each participating ICU could include either
consecutive patients admitted over a six-month period or
the first 20 consecutive patients fulfilling the inclusion
criteria (all patients aged 80 years or older). The data
collection for VIP1 took place between October 2016 and
February 2017 and between May 2018 to May 2019 for
VIP2. Both studies used similar inclusion criteria as de-
scribed elsewhere [13]. Informed consent was obtained
from study participants. Local ethical committees might
have waived the need of informed consent.
In this post-hoc analysis of these two studies, all pa-
tients admitted acutely (non-electively) with complete
data on age, gender, clinical frailty score (CFS), sequen-
tial organ failure assessment (SOFA) score, and ICU
mortality were included. For this study, the elective pa-
tients included in VIP1 were excluded as their outcomes
differ significantly compared with those admitted
acutely, as previously shown [18]. The primary endpoint
of this study was ICU-mortality, and the secondary end-
point was 30-day-mortality.
Scales, scores, and limitations in life-sustaining therapy
The SOFA score was recorded on admission; it could be
calculated manually or using an online calculator. Frailty
was assessed by the clinical frailty scale (CFS). The CSF
distinguishes nine classes of frailty from very fit (CFS 1)
to terminally ill (CFS 9). The respective visual and sim-
ple description for this assessment tool was used with
permission [19–21].
The Katz Activities of Daily Living (Katz ADL) scale is
a widely used graded instrument to assess disability in
chronically ill or older patients. It evaluates six primary
and psychosocial functions: bathing, dressing, going to
the toilet, transferring, feeding, and continence. The pa-
tient receives 1 point for every independent and 0 for
every dependent activity (6 = independent patient, 0 =
very dependent patient). For the patients in the VIP2
trial, disability was defined by Katz ADL score ≤ 4.
For cognitive decline, VIP2 utilised the Short form of
Informant Questionnaire on Cognitive Decline in the
Elderly (IQCODE). IQCODE is a questionnaire, com-
pleted by carers, with 16 questions about cognitive de-
cline over the past 10 years. For each question, 1 to 5
points can be assigned. An average of 3 points per ques-
tion is considered “normal”. A cumulative IQCODE of
≥3.5 is regarded as “cognitive decline” [19–21].
The burden of co-morbidity was assessed using the
co-morbidity and polypharmacy score (CPS) [22]. The
CPS calculates the total number of chronic diagnoses
and drugs taken. Standard ICU procedures were also
documented.
In addition, limitations of therapy, such as withholding
or withdrawing treatment, were recorded. Withholding
life-sustaining therapy (e.g. mechanical ventilation, renal
replacement therapy, cardiopulmonary resuscitation)
was defined as not performing a measure that was indi-
cated; withdrawing was defined as stopping any kind of
life-sustaining therapy. All these decisions were at the
discretion of the treating physicians and documented
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according to international recommendations. VIP2 re-
corded the exact date of treatment limitation, but VIP1
did not give specific details. Thus, the present analysis
used withholding or withdrawing treatment as binary
information at any time during the ICU-stay.
Statistical analysis
Post-hoc power calculations using the 7110 octogenar-
ians and 790 nonagenarians, primary outcome event
rates of 40% versus 45%, and an alpha of 0.05, the power
of the study to detect differences in 30-day mortality is
77%. Continuous data points are expressed as median ±
interquartile range. Differences between independent
groups were calculated using the Mann Whitney U-test.
Categorical data are expressed as numbers (percentage).
The chi-square test was applied to calculate differences
between groups. Sensitivity analysis, analysing only pa-
tients with SOFA scores below the 75th percentile SOFA
score of 10 (i.e. all patients with SOFA < 10) was per-
formed. Univariable and multivariable logistic regression
analysis was performed to assess associations with treat-
ment limitations and mortality. Odds ratios (OR) and
adjusted odds ratios (aOR) with respective 95% confi-
dence intervals (CI) were calculated. Two sequential ran-
dom effects, multilevel logistic regression models were
used to evaluate the impact of being a nonagenarian on
ICU- and 30-days- mortality. All patients with valid data
on ICU-mortality were included. First, a baseline model
with being nonagenarian as a fixed effect and ICU as
random effect (model-1) was fitted. Second, to model-1,
patient characteristics (SOFA, CFS, sex) (model-2) were
added to the model. Adjusted odds ratios (aOR) with re-
spective 95% confidence intervals (CI) were calculated.
Sensitivity analysis, analysing only patients with and
without any treatment limitation was performed. All
tests were two-sided, and a p-value of < 0.05 was consid-
ered statistically significant. SPSS version 23.0 (IBM,
USA) and MedCalc Statistical Software version 19.1.3
(MedCalc Software bv, Ostend, Belgium; https://www.
medcalc.org; 2019) were used for all statistical analyses.
Results
Study population
This study included 7900 patients. 10% of the patients
were nonagenarians. Table 1 displays the baseline
characteristics of nonagenarians versus octogenarians.
Nonagenarians were predominantly female (57% versus
46%, p < 0.001), evidenced higher rates of frailty (58% vs
42%; p < 0.001), disability (44% vs. 26%; p < 0.001) and
cognitive decline (50% vs. 31%; p < 0.001) but lower
SOFA scores at admission (6 + 5 vs. 7 + 6; p < 0.001).
Specific ICU-treatment strategies were used, with octo-
genarians receiving higher rates of organ support (renal
replacement therapy, mechanical ventilation, vasoactive
drugs), while for nonagenarians there were higher rates
of treatment limitation (40% vs. 33%; p < 0.001; Table 1).
After discharge from the ICU, most patients had a
treatment limitation; 1053 octogenarians (55% of all
octogenarians leaving the ICU alive) and 182 (85%)
nonagenarians left the ICU with treatment limitations
in place.
Survival analysis in the total cohort
The overall ICU mortality was 27% (N = 2134 of 7900
patients), the 30-day-mortality was 39% (N = 3080 of
7555 patients). Compared to the octogenarians the
nonagenarians had a similar ICU mortality (27% vs.
27%; p = 0.973), but a higher 30-day-mortality (45%
vs. 40%; p = 0.029, Fig. 1). Nonagenarians showed a
significantly longer length of ICU-stay (84 h versus 54
h, p < 0.001).
Comparison of nonagenarians versus octogenarians in
the multilevel logistic regression models
After the adjustment for the ICU cluster as a random
effect (model-1), nonagenarians had an increased risk for
withholding life-sustaining therapy (aOR 1.54 (95% CI
1.22–1.94; p = < 0.001)), but not for withdrawal (aOR
1.03 (95% CI 0.77–1.39; p = 0,82)). Nonagenarians re-
ceived significantly less mechanical ventilation, renal re-
placement therapy and vasoactive drugs. There was no
difference between both age groups regarding the use of
mechanical ventilation, vasopressors, and ICU-mortality,
but an increased risk for 30-day-mortality (aOR 1.39
(95% CI 1.13–1.72); p = 0.002). After adding patient-
specific confounders (model-2), nonagenarians demon-
strated no significant risks compared to octogenarians
(Table 2)
Discussion
This study examines the largest multi-centre prospect-
ively recruited group of intensive care patients of 90
years and older published to date. Nonagenarians differ
in their baseline risk distribution, management, and clin-
ical outcomes from octogenarians. Nonagenarians had
higher rates of frailty, cognitive impairment, and disabil-
ity. However, when compared with octogenarians, nona-
genarians had a lower illness severity and required less
organ support. After adjustment for relevant con-
founders, the 30-day mortality did not differ between
both groups.
Our results are in line with other studies looking at
older ICU patients: Fuchs et al. evaluated a cohort of
more than 7000 surgical and medical ICU patients and
found age, especially above 75 years, to be an independ-
ent risk factor for mortality [9, 23]. In a large retrospect-
ive analysis of 1,807,531 patients admitted to an ICU
between 1997 and 2016, Jones et al. reported increased
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mortality in patients older than 84 years, although they
had a similar illness severity at ICU admission compared
to younger patients [23]. Conversely, in a study evaluat-
ing 5882 patients after cardiac arrest, age alone was only
a weak predictor of mortality [24]. In a recent study by
Roedl et al., a survival rate of 46% with a good neuro-
logical outcome was reported for nonagenarians after
cardiac arrest [11]. Recently, Druwé et al. performed a
subgroup analysis on out-of-hospital cardiac arrests with
a special interest in the resuscitation attempts in octoge-
narians: Most physicians considered cardiopulmonary
resuscitation to be appropriate even in older patients
with poor outcome perspectives [25]. Furthermore, in
another study by Becker et al., the ICU mortality of no-
nagenarians was low at 30% and, importantly, the one-
year survival was 50%, indicating outcomes “better than
expected” in nonagenarians [26]. Of note, the study by
Becker et al. was a single-centre study, and the number
Table 1 Baseline characteristics in the total cohort, nonagenarians versus octogenarians
nonagenarians octogenarians p-value
n = 790 n = 7110
Male sex n (%) 339 (43%) 3812 (54%) < 0.001
Age
median (±IQR) 91 (90–93) 83 (81–86) < 0.001
Frailty Score - CFS
median (±IQR) 5 (4–6) 4 (3–6) < 0.001
Frailty (CFS > 4) n (%) 454 (58) 2962 (42) < 0.001
ADL
median (±IQR) 5 (3–6) 6 (4–6) < 0.001
Disability (ADL ≤4) 151 (44) 805 (26) < 0.001
IQCODE
median (±IQR) 3.5 (3–4) 3.2 (3–4) < 0.001
Cognitive Decline (IQCODE ≥3.5) 149 (50) 812 (31) < 0.001
SOFA score 6 (4–9) 7 (4–10) < 0.001
median (±IQR)
ICU length of stay (hours)
median (±IQR) 84 (24–117) 54 (37–186) < 0.001
Treatment withdrawn and/or withheld (%) 312 (40) 2302 (33) < 0.001
NIV n (%) 168 (21) 1794 (23) 0.03
Intubation n (%) 324 (41) 3685 (52) < 0.001
Renal replacement therapy n (%) 33 (4) 816 (12) < 0.001
Vasoactive drugs n (%) 414 (52) 4179 (59) 0.002
Admission diagnosis n (%) < 0.001
Respiratory failure 155 (20) 1745 (23)
Circulatory failure 136 (17) 968 (14)
Combined circulatory & respiratory failure 104 (13) 825 (12)
Sepsis 74 (9) 966 (14)
Multitrauma w/o Head Injury 23 (3) 128 (2)
Trauma with Head Injury 18 (2) 124 (2)
Head Injury 29 (4) 166 (2)
Intoxication 1 (< 1) 36 (< 1)
Cerebral Injury (Non-Traumatic) 38 (5) 469 (7)
Emergency Surgery 91 (12) 817 (12)
Other 91 (12) 866 (12)
CFS Clinical Frailty Scale, SOFA Sequential Organ Failure Assessment, ADL Activity of Daily Life measured with the Katz index, IQCODE Informant Questionnaire on
COgnitive Decline in the Elderly, ICU Intensive Care Unit, NIV Non-Invasive Ventilation, SD Standard Deviation
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of patients who received vasoactive drugs was lower
when compared to the patients in our multi-centre
study. Therefore, we propose the higher mortality rates
reported in the present study may be more representa-
tive of a “real-world scenario”.
Demoule et al. performed a matched case-control
study in 36 nonagenarians admitted to an ICU. They
were matched according to sex with 72 controls: ICU
admissions chosen from the 20- to 69-year age range.
They found no differences in the reason for
admission, but nonagenarians suffered significantly
less from pre-existing co-morbidities. Advanced life-
support interventions were used equally. ICU and
intra-hospital mortality, as well as the length of stay,
did not differ significantly between nonagenarians and
the control group [27]. Despite differences in the
absolute length of stay, the trend of a shorter length
of stay for older (nonagenarian) intensive care pa-
tients is consistent with previous studies [28].
Interestingly, being a nonagenarian was independently
associated with the decision for withholding life-
sustaining therapy, but not for withdrawing it. After
adjustment for patient characteristics, nonagenarians ev-
idenced no particular risk for treatment limitations
Fig. 1 Comparison of 30-day and ICU-mortality. A: ICU-mortality [%], B: 30-day-mortality [%]. * = p < 0.05
Table 2 Associations of primary exposure (being nonagenarian) with mortality and management strategies in a multilevel logistic
regression model
octogenarians nonagenarians p-value model-1 model-2
Treatment withheld 27% (1945) 35% (279) < 0.001 aOR 1.54
(95% CI 1.22–1.94; p = < 0.001)
aOR 0.95
(95% CI 0.67–1.36; p = 0.79)
Treatment withdrawn 14% (1026) 13% (102) 0.24 aOR 1.03
(95% CI 0.77–1.39; p = 0.82)
aOR 0.73
(95% CI 0.48–1.10; p = 0.13)
NIV 25% (1794) 21% (168) 0.014 aOR 0.79
(95% CI 0.61–1.03; p = 0.08)
aOR 0.85
(95% CI 0.59–1.22; p = 0.36)
Mechanical Ventilation 52% (3685) 41% (324) < 0.001 aOR 0.72
(95% CI 0.56–0.93; p = 0.01)
aOR 1.26
(95% CI 0.85–1.87; p = 0.26)
RRT 11% (816) 4% (33) < 0.001 aOR 0.32
(95% CI 0.19–0.53; p = < 0.001)
aOR 0.55
(95% CI 0.28–1.08; p = 0.08)
Vasoactive drugs 59% (4179) 52% (414) < 0.001 aOR 0.74
(95% CI 0.58–0.95; p = 0.017)
aOR 0.90
(95% CI 0.60–1.35; p = 0.62)
30d Mortality 40% (2743) 44% (337) 0.029 aOR 1.39
(95% CI 1.13–1.72); p = 0.002)
aOR 1.25
(95% CI 0.90–1.74; p = 0.19)
ICU-Mortality 27% (1921) 27% (213) 0.97 aOR 1.10
(95% CI 0.87–1.40); p = 0.43)
aOR 0.91
(95% CI 0.63–1.32; p = 0.63)
NIV Non-Invasive Ventilation, RRT renal replacement therapy, ICU Intensive Care Unit, aOR Adjusted Odds Ratio, 95% CI 95% Confidence Interval
Model 1 - ICU cluster (the patient’s individual ICU) as random effect
Model 2 - Model 1 plus patient level (SOFA, CFS, age, sex)
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compared to octogenarians. These findings contradict
the usual expectation that physicians in general tend to
be more reluctant to provide organ support to nonage-
narians compared to similarly sick octogenarians. In no-
nagenarians, ICU re-triage should be emphasised: after
an initial intensive care treatment for up to 48 h, patients
should be critically evaluated in cooperation with their
family and/ or carers and discharged to a normal ward
for best-supportive care if further intensive care seems
unethical, unjustified, or unlikely to improve outcomes.
However, modern intensive care medicine is not limited
to life-sustaining measures. Even beyond invasive venti-
lation, renal replacement therapy or cardiopulmonary re-
suscitation, intensive care medicine can provide valuable
treatment for the patient, which might be intensified pal-
liative therapy. Based on our data, being a nonagenarian
does not represent a particular risk factor for adverse
outcomes. Application of ICU re-triage could help to re-
duce the economic burden of ICU care in very old pa-
tients, in addition to unethical intensive care and
distress caused to health care providers.
Mortality was similar between octogenarians and no-
nagenarians at ICU discharge and after 30 days. The
long-term outcomes of the VIP2 study are awaited and
will answer the question of whether this effect remains
stable further over time.
An important limitation is, that we have no infor-
mation about pre-ICU triage decisions, although this
might be an important factor for the differences in
disease illness scores and frailty between nonagenar-
ians and octogenarians. Furthermore, this study only
provides detailed information up to ICU-discharge
and there was a significant rise in mortality during
the 30 days after ICU-discharge, but we do not have
detailed data on decisions made and developments
during this period. Another limitation is that no a
priori sample size calculation was made to detect a
difference in the mortality between nonagenarians and
octogenarians. Our post-hoc power calculation shows
that the present study is likely underpowered for the
primary outcome, and thus the reporting results that
are at a higher risk of false positive results. However,
this was counterbalanced by using a multilevel model
to adjust for relevant confounders.
Conclusion
Nonagenarian ICU patients demonstrated higher rates of
frailty but had less acute organ dysfunction than
octogenarians. After adjustment for multiple relevant
confounders, nonagenarians did not suffer from worse
outcomes compared to octogenarian ICU patients.
Rather than being a nonagenarian, the severity of illness,
functional capacity – and of course the patients’ will -
should guide triage decisions.
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